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Abstract
Sedoheptulose- 7- phosphate isomerase, GmhA, is the first enzyme in the biosynthesis 
of nucleotide- activated- glycero- manno- heptoses and an attractive, yet underexploited, 
target for development of broad- spectrum antibiotics. We demonstrated that GmhA 
homologs in Neisseria gonorrhoeae and N. meningitidis (hereafter called GmhAGC and 
GmhANM, respectively) were interchangeable proteins essential for lipooligosaccha-
ride (LOS) synthesis, and their depletion had adverse effects on neisserial viability. In 
contrast, the Escherichia coli ortholog failed to complement GmhAGC depletion. 
Furthermore, we showed that GmhAGC is a cytoplasmic enzyme with induced expres-
sion at mid- logarithmic phase, upon iron deprivation and anaerobiosis, and conserved 
in contemporary gonococcal clinical isolates including the 2016 WHO reference 
strains. The untagged GmhAGC crystallized as a tetramer in the closed conformation 
with four zinc ions in the active site, supporting that this is most likely the catalytically 
active conformation of the enzyme. Finally, site- directed mutagenesis studies showed 
that the active site residues E65 and H183 were important for LOS synthesis but not 
for GmhAGC function in bacterial viability. Our studies bring insights into the impor-
tance and mechanism of action of GmhA and may ultimately facilitate targeting the 
enzyme with small molecule inhibitors.
K E Y W O R D S
crystal structure, drug target, Neisseria gonorrhoeae, sedoheptulose-7-phosphate isomerase 
GmhA
1  | INTRODUCTION
The World Health Organization (WHO) and the Centers for Disease 
Control and Prevention (CDC) emphasized an urgent need for the 
development of antimicrobials with novel modes of action against 
antibiotic- resistant threats with severe consequences for public health, 
including infections caused by drug- resistant Neisseria gonorrhoeae 
(Centers for Disease Control and Prevention, 2013a, 2013b; World 
Health Organization, 2012, 2015). Gonorrhea is highly prevalent 
throughout the world, and if untreated or inadequately treated, often 
leads to serious repercussions on reproductive health including ecto-
pic pregnancy, pelvic inflammatory disease, and infertility (Centers For 
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Disease Control And Prevention, 2013b, Low, Unemo, Skov Jensen, 
Breuer, & Stephenson, 2014; World Health Organization, 2011). In 
the absence of a protective gonorrhea vaccine, antibiotics remain the 
sole therapeutic intervention. However, the well- documented ability 
of gonococci to acquire antibiotic resistance continues to threaten 
available treatment options (Unemo, 2015; Unemo & Shafer, 2014). 
To meet the needs raised by WHO and CDC, our laboratory focuses on 
identification and validation of new molecular targets for the develop-
ment of gonorrhea treatments (Bonventre, Zielke, Korotkov, & Sikora, 
2016; Zielke, Wierzbicki, Baarda, & Sikora, 2015; Zielke, Wierzbicki, 
Weber, Gafken, & Sikora, 2014; Zielke et al., 2016).
Targeting the first enzymes in the nucleotide- activated- glycero- 
manno- heptose pathways is a relatively unexplored field, although 
it appears to be an alternative approach to the discovery of broad- 
spectrum antibacterial drugs (Bauer, Stevens, & Hansen, 1998; Darby, 
Ananth, Tan, & Hinnebusch, 2005; Tamaki, Sato, & Matsuhashi, 1971; 
Valvano, Messner, & Kosma, 2002). Nucleotide- activated- glycero- 
manno- heptoses, while absent in eukaryotic cells, are widely present in 
bacteria and are crucial components of the lipopolysaccharides (LPS), 
lipooligosaccharides (LOS), capsules, O-antigens, and glycan moieties 
of bacterial cell surface (S- layer) glycoproteins (Valvano et al., 2002). 
In particular, one such potential drug target of significant  interest is 
sedoheptulose- 7- phosphate isomerase, GmhA, annotated previously 
as TfrA (Havekes, Lugtenberg, & Hoekstra, 1976) and LpcA (Brooke 
& Valvano, 1996a). GmhA is conserved in many Gram- negative and 
some Gram- positive bacteria and is responsible for catalyzing isom-
erization of the D- sedoheptulose 7- phosphate into D- glycero- α,β- D- 
manno- heptose- 7- phosphate (Eidels & Osborn, 1974), which is the 
first and common step for parallel biosynthetic pathways leading to 
generation of GDP- D- glycero- α- D- manno- heptose (D,D- heptose) 
and ADP- L- glycero- β- D- manno- heptose [L,D- heptose; reviewed in 
Ref: (Valvano et al., 2002)]. D,D- heptose is required for glycosyla-
tion of flagella and capsular polysaccharides, and for the assembly 
of disaccharide repeating units (D,D- heptose linked to L- rhamnose) 
composing the S- layer glycan in the Gram- positive Eubacterium, 
Aneurinibacillus thermoaerophilus DSM 10155 (Eidels & Osborn, 1974; 
Kosma, Wugeditsch, Christian, Zayni, & Messner, 1995; Wugeditsch 
et al., 1999). L,D- heptose is used for glycosylation of capsular polysac-
charides (Valvano et al., 2002) and as a primary building block of LPS/
LOS core oligosaccharide (Brooke & Valvano, 1996a; Eidels & Osborn, 
1971). In addition, a large family of bacterial autotransporter heptos-
yltransferases (BAHTs) utilizes L,D- heptose as a sugar donor to modify 
serine residues on their substrate autotransporters, which has a signif-
icant impact on the virulence of Gram- negative pathogens (Lu, Li, & 
Shao, 2015). The L,D- heptose is synthesized in sequential reactions 
catalyzed in order by GmhA- HldE(HldA)- GmhB- HldE(HldC)- HldD 
[reviewed in Refs: (Raetz & Whitfield, 2002; Valvano et al., 2002)]. 
Usually one or more L,D- heptose molecules and two 2- keto- 3- deoxy- 
D- manno- oct- 2- ulosonic acid (KDO) residues form the inner portion 
(lipid A proximal) of the LPS/LOS core oligosaccharide, which is typi-
cally more conserved than the structurally diverse outer core (Raetz & 
Whitfield, 2002). Similarly, gonococcal LOS contain two basal heptose 
molecules, designated Hep I and Hep II, forming elongation centers 
α, β, and χ (Gibson et al., 1989; John, Griffiss, Apicella, Mandrell, 
& Gibson, 1991; Yamasaki, Bacon, Nasholds, Schneider, & Griffiss, 
1991). The individual chains can be decorated with structures that 
mimic human carbohydrate epitopes (α chain linked to Hep I; Apicella 
& Mandrell, 1989); a single glucose, lactose, or glucose with additional 
sugars (β chain extending from Hep II; Gibson et al., 1989; Yamasaki 
et al., 1994); and GlcNac, GlcNac acetate, or occasionally galactose 
(χ chain; Mcleod Griffiss, Brandt, Saunders, & Zollinger, 2000). In ad-
dition, phosphate or phosphoethanolamine groups may be attached 
to the heptose residues (Preston, Mandrell, Gibson, & Apicella, 1996; 
Raetz & Whitfield, 2002). The phosphoric residues participate in the 
ionic interactions between LPS/LOS and outer membrane proteins, as 
well as divalent cations, providing a barrier against entry of detergents, 
antibiotics, and hydrophobic compounds (Preston et al., 1996; Raetz 
& Whitfield, 2002). The N. gonorrhoeae heptose- monophosphate was 
recently linked with the clinical and epidemiological synergy of gon-
orrhea and HIV (Malott et al., 2013). At the molecular level, this in-
terplay involves the unique ability of gonococci to efficiently liberate 
phosphorylated L,D- heptose into the extracellular milieu, which elicits 
an immune response and induces HIV- 1 expression and viral produc-
tion in cluster of differentiation 4- positive (CD4+) T cells (Malott et al., 
2013).
Mutations in genes encoding GmhA in different bacterial species 
examined to date resulted in pleiotropic effects including produc-
tion of truncated LPS/LOS composed of lipid A and KDO residues, 
increased susceptibility to antibiotics and detergents, impaired bio-
film formation, and attenuated virulence (Aballay, Drenkard, Hilbun, 
& Ausubel, 2003; Bauer et al., 1998; Brooke & Valvano, 1996b; Darby 
et al., 2005). In addition, lack of HldA, which acts immediately down-
stream from GmhA in the L,D- heptose biosynthetic pathway, ren-
dered gonococci unable to induce HIV- 1 expression (Malott et al., 
2013). Therefore, we propose GmhA in N. gonorrhoeae, GmhAGC, as 
a molecular target for the development of new antigonococcal drugs. 
Herein, we performed characterization of GmhAGC at the molecular, 
functional, and structural levels to facilitate the future targeting of this 
enzyme with small molecule inhibitors.
2  | EXPERIMENTAL PROCEDURES
2.1 | Bacterial strains and growth conditions
Strains of bacteria used in this study are listed in Table 1. Neisseria 
gonorrhoeae and N. meningitidis were cultured either on gonococcal 
base solid medium (GCB, Difco), or in gonococcal base liquid (GCBL) 
 medium supplemented with Kellogg’s supplement I and II in ratios 
1:100 and 1:1,000, respectively (Spence, Wright, & Clark, 2008). 
GCBL was additionally supplemented with sodium bicarbonate at a 
final concentration of 0.042%. In vitro host- relevant growth condi-
tions (iron deprivation, presence of normal human serum, anoxia) 
were procured as described previously (Zielke et al., 2016). Neisseria 
were cultured on solid media for 18–22 hr at 37°C in the presence of 
5% atmospheric CO2. For N. gonorrhoeae, piliated or nonpiliated vari-
ants were passaged onto GCB and incubated for additional 18–22 hr. 
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Colonies with piliated morphology were used for DNA transforma-
tion, while nonpiliated variants were used in all other experiments. 
Escherichia coli strains were grown either on Luria–Bertani agar (LBA, 
Difco) or cultured in Luria–Bertani broth (LB, Difco) at 37°C.
Antibiotics were used on selected bacteria in the following con-
centrations: for N. gonorrhoeae: kanamycin 40 μg/ml, erythromycin 
0.5 μg/ml; for N. meningitidis: kanamycin 80 μg/ml, erythromycin 2 μg/
ml; for E. coli: kanamycin 50 μg/ml, erythromycin 250 μg/ml.
2.2 | Genetic manipulations, site- directed 
mutagenesis, and transcomplementation
Plasmids and primers used in this study are listed in Table S1. 
Oligonucleotides were designed based on the genomic sequence 
of N. gonorrhoeae FA1090 (NC_002946), N. meningitidis MC58 
(NC_003112), and E. coli BL21(DE3) (NC_012892) using SnapGene 
software version 2.8 (GSL Biotech LLC) and synthesized by IDT 
Technologies. Genomic DNA of gonococcal strains, N. meningitidis 
MC58, and E. coli BL21(DE3) was isolated with the Wizard Genomic 
DNA Purification Kit (Promega). PCR products and plasmid DNA were 
purified using QIAprep Spin Miniprep Kit (QIAGEN). PCR reactions 
were performed using chromosomal or plasmid DNA as template, ap-
propriate oligonucleotides, and Q5® High- Fidelity DNA Polymerase 
(NEB). E. coli MC1061 was used as the host during the molecular 
cloning and site- directed mutagenesis procedures. All created con-
structs and suppressor mutations in ∆gmhAGC/Plac::gmhAGC were veri-
fied by Sanger Sequencing at the Center for Genomic Research and 
Biocomputing at Oregon State University. Transformation of N. gon-
orrhoeae and N. meningitidis was performed as described previously 
(Alexander, Richardson, & Stojiljkovic, 2004; Zielke et al., 2014).
The recombinant GmhAGC (rGmhAGC) containing N- terminal- 6 × 
His- tag followed by the tobacco etch virus (TEV) protease recognition 
site was obtained by amplifying the DNA region of the ngo1986 lacking 
stop codon with primers rNGO1986- F and rNGO1986- R and cloning 
the obtained PCR product (615 bp) into NcoI/HindIII sites of pRSF- NT 
(Table S1).
The conditional GmhAGC mutant, FA1090 ∆gmhAGC/Plac::gmhAGC, 
was constructed using a strategy as described by (Zielke et al., 2016) 
by placing an additional copy of ngo1986 under the control of the 
isopropyl β- D- 1- thiogalactopyranoside (IPTG)- inducible promoter, 
Plac, within an intergenic region located between lctP and aspC in 
the FA1090 chromosome (Mehr, Long, Serkin, & Seifert, 2000) and a 
subsequent in- frame replacement of the ngo1986 in its native chro-
mosomal locus with the nonpolar kanamycin resistance cassette. 
Specifically, the ngo1986 containing its native ribosomal binding site 
(RBS) was amplified with primers NGO1986- RBS- F and NGO1986- 
RBS- R. The resulting 628 bp PCR product was digested with FseI and 
inserted into ScaI/FseI- treated pGCC4, yielding pGCC4- GmhAGC. 
After transformation of FA1090 with pGCC4- GmhAGC, gonococci 
were selected on GCB with 0.5 μg/ml erythromycin and verified by 
PCR with primers pGCC4- Ver- F and pGCC4- Ver- R.
The constructs for deletion of gmhAGC were obtained by amplifi-
cation of the 552 bp upstream DNA region and 571 bp downstream 
from ngo1986 with primers NGO1986- UP- F/NGO1986- UP- R and 
NGO1986- Down- F/NGO1986- Down- R, respectively. The upstream 
fragment was digested with EcoRI/KpnI and cloned into similarly 
cleaved pUC18K, yielding pUC18K- GmhAGC- Up. Next, the down-
stream fragment was inserted into the BamHI/HindIII- cleaved 
pUC18K- GmhAGC- Up. The resulting pUC18K- GmhAGC was linear-
ized with HindIII and used to transform FA1090 carrying the sec-
ond copy of GmhA on the chromosome, FA1090Plac::gmhAGC. Clones 
were selected on a solid medium supplemented with kanamycin and 
0.1 mmol/L IPTG, and verified by PCR with NGO1986- Ver- F and 
NGO1986- Ver- R primers. Subsequently, selected gonococci were fur-
ther verified by immunoblotting analyses using anti- GmhAGC antisera.
To generate GmhAGCE65A and GmhAGCH183A, the template 
for site- directed mutagenesis (pUC18- GmhAGC) was constructed by 
amplifying ngo1986 with its native RBS using primers NGO1986- 
RBS- F and NGO1986- RBS- R and cloning into SmaI- cleaved pUC18. 
Site- directed mutagenesis was performed using the template; primer 
pairs E65A- F/E65A- R or H183A- F/H183A- R, respectively, and Q5 
TABLE  1 Bacterial strains used in this study
Bacterial strains Reference
N. gonorrhoeae
FA1090 (Connell et al., 
1988)
MS11 (Meyer, Mlawer, & 
So, 1982)
1291 (Apicella, Breen, & 
Gagliardi, 1978)
F62 (Sparling, 1966)
FA1090 ∆gmhAGC/Plac:: gmhAGC This study
FA1090 ∆gmhAGC/Plac:: gmhAGC E65A This study
FA1090 ∆gmhAGC/Plac:: gmhAGC H183A This study
FA1090 ∆gmhAGC/Plac:: gmhANM This study
Baltimore collection 1991–1994: 
LGB1, LG14, LG2, LGB26, LG20
(Garvin et al., 2008; 
Zielke et al., 2014)
Clinical isolates from Public Health–Seattle 
& King County Sexually Transmitted 
Disease Clinic: 
UW01, UW02, UW03, UW04, UW05, 
UW06, UW07, UW08, UW09, UW10, 
UW11, UW12, UW13
(Zielke et al., 2016)
2016 WHO reference strains:F, G, K, L, M, 
N, O, P, W, X, Y, Z, U, V
(Unemo et al., 2016)
N. meningitidis
MC58 (McGuinness et al., 
1991)
MC58 ∆gmhANM/Plac:: gmhANM This study
MC58 ∆gmhANM/Plac:: gmhAGC This study
E. coli
MC1061 (Casadaban & 
Cohen, 1980)
BL21(DE3) (Studier & Moffatt, 
1986)
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Site- Directed Mutagenesis Kit (NEB), according to the manufacturer’s 
manual. Subsequently, the mutated variants of GmhAGC were ampli-
fied with NGO1986- RBS- F and NGO1986- RBS- R, cleaved with FseI, 
cloned into ScaI/FseI- digested pGCC4, introduced into the FA1090 
chromosome, and the native ngo1986 was deleted as described above.
For transcomplementation studies, GmhA homologs from N. men-
ingitidis MC58 (nmb2090) and E. coli BL21(DE3) (ECBD_3400) were 
amplified with primer pairs NGO1986- RBS- F/NGO1986- RBS- R and 
ECBD3400- RBS- F, respectively. The resulting PCR products were 
digested with FseI and introduced into ScaI/FseI- treated pGCC4. 
Introduction into the FA1090 chromosome and deletion of GmhA 
were performed as outlined above.
The cytoplasmic marker control for subfractionation experi-
ments, the zwf gene (ngo0715) encoding glucose- 6- phosphate- 1- 
dehydrogenase was amplified using primers RAZ548 and RAZ549. 
The PCR product was cleaved with NcoI and HindIII and cloned into 
similarly digested pRSF- NT to obtain plasmid pRSF- NT- Zwf.
2.3 | Proteome subfractionation procedures
Colonies of N. gonorrhoeae FA1090 were collected from GCB, sus-
pended in 500 ml of GCBL to OD600 of 0.1, and cultured with aera-
tion at 37°C until OD600 of ~0.8. Bacterial cells were separated from 
the suspension by centrifugation (10 min, 6,000g, 4°C). The crude cell 
envelopes were purified using a sodium carbonate extraction proce-
dure while naturally released membrane vesicles (MVs) and soluble 
proteins (SS) were fractionated from culture supernatants by ultracen-
trifugation as described previously (Zielke et al., 2016).
2.4 | GmhAGC depletion studies
Colonies of FA1090 ∆gmhAGC/Plac:: gmhAGC were collected with a 
cotton swab from GCB supplemented with 10 μmol/L IPTG and sus-
pended in GCBL to OD600 of 0.1. After two washes in prewarmed 
GCBL, bacterial suspension was split and incubated with shaking 
(220 rpm) with or without IPTG for 3 hr at 37°C. Cultures were back- 
diluted to OD600 of 0.1 in fresh GCBL, as described above, and cul-
tured for additional 6 hr. At specific time points indicated in the text, 
OD600 measurements were taken, samples for western blotting and 
LOS isolation were withdrawn, and cultures were serially diluted fol-
lowed by plating on GCB for enumeration of colony- forming units 
(CFUs). Experiments were performed on three separate occasions and 
mean values and SEM are presented.
2.5 | Isolation of LOS and silver staining
LOS was isolated from N. gonorrhoeae and N. meningitidis based on 
the method described previously (Hitchcock & Brown, 1983). Bacteria 
were either collected from GCB or GCBL, as specified in the text, sus-
pended in 1.5 ml of GCBL to OD600 of 0.2 and spun down for 1.5 min 
at 15,000g. Pelleted cells were lysed by addition of 50 μl of lysis buffer 
(2% SDS, 4% β- mercaptoethanol, 10% glycerol, 1mol/L Tris- HCl 
pH 6.8, and 0.01% bromophenol blue) and incubation at 100°C for 
10 min. Samples were allowed to cool down to room temperature and 
proteins were digested by addition of 25 μg proteinase K in 10 μl of 
lysis buffer and incubated for 1 hr at 60°C. Isolated LOS was resolved 
on 16.5% Mini- PROTEAN® Tris- Tricine Gel (Bio- Rad) and visualized 
by a silver staining procedure (Tsai & Frasch, 1982).
2.6 | Fitness assessment
Colonies of different neisserial strains, as indicated in the text, were 
collected from GCB and reconstituted in GCBL to OD600 of 0.1. 
Bacterial cultures were incubated in the absence of IPTG for 3 hr at 
37°C with aeration and subsequently back- diluted to OD600 of 0.2, 
serially diluted, and plated on GCB with or without IPTG for CFUs 
scoring. Experiments were repeated in three biological replicates and 
mean values with corresponding SEM are presented.
2.7 | Purification of the rGmhAGC and rZwf and 
production of polyclonal rabbit antibodies
E. coli BL21(DE3) strain carrying either pRSF- NT- GmhAGC or pRSF- 
NT- Zwf was used as heterologous host for overproduction and pu-
rification of rGmhAGC and recombinant Zwf (rZwf), respectively. 
Overnight cultures were back- diluted in 2.0 L of LB supplemented 
with kanamycin and incubated with aeration at 37°C until the opti-
cal density (OD600) reached ~0.5. Overproduction of rGmhAGC and 
rZwf was induced with 0.1 and 1 mmol/L IPTG, respectively, and 
cultures were incubated for additional 3 hr at 37°C. Cells were har-
vested by centrifugation (6,000g, 10 min, 4°C). Pelleted bacteria car-
rying pRSF- NT- GmhAGC were suspended in lysis buffer (20 mmol/L 
Tris- HCl pH 7.0, 1 mol/L NaCl, 10 mmol/L imidazole, 5% glycerol) 
supplemented with a Pierce Protease Inhibitor Mini Tablet (Thermo 
Scientific) and lysed by passaging six times through a French pres-
sure cell at 12,000 psi. Cell debris and unbroken cells were separated 
from soluble protein fraction by centrifugation at 16,000g for 30 min 
at 4°C. The supernatant was passed through 0.22 μm membrane filter 
(VWR International) and applied onto Bio- Scale MiniProfinity IMAC 
cartridges (Bio- Rad) on the NGC Scout Chromatography system (Bio- 
Rad). Loosely bound proteins were removed with 10 column volumes 
of wash buffer (20 mmol/L Tris pH 8.0, 500 mmol/L NaCl, 40 mmol/L 
imidazole) and elutions were conducted with a 40–250 mmol/L 
imidazole gradient. Fractions containing rGmhAGC were combined 
and a PD- 10 column (GE Healthcare) was used to exchange the 
buffer to 20 mmol/L HEPES pH 7.5, 100 mmol/L NaCl, 5% glycerol. 
Subsequently, the N- terminal- 6 × His- tag of the rGmhAGC was re-
moved by TEV protease. Cleavage reaction was prepared by mixing 
rGmhAGC with TEV in 20:1 (w:w ratio) in 500 μl of cleavage buffer 
(0.5 mol/L Tris- HCl pH 8.0, 5 mmol/L EDTA), 10 μl of 0.5 mol/L DTT, 
and 500 μl of Ni- NTA agarose (Qiagen) equilibrated with cleavage 
buffer. Following overnight incubation at room temperature, cleav-
age mixture was loaded onto a 5 ml polypropylene column (Thermo 
Scientific) and supernatant containing 6 × His- tag- free rGmhAGC was 
collected. To remove residual TEV protease that coeluted with rGm-
hAGC, the mixture was incubated again with 500 μl of Ni- NTA agarose 
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(Qiagen) equilibrated with cleavage buffer for 1 hr with rotation at 
4°C, and rGmhAGC was eluted. The purified rGmhAGC was applied to a 
PD- 10 column (GE Healthcare) for a buffer exchange into 20 mmol/L 
HEPES pH 7.5, 100 mmol/L NaCl, and 5% glycerol.
Purification of rZwf was accomplished using the same procedures 
as described above with the following modifications. E. coli cells were 
resuspended in lysis buffer (20 mmol/L Tris- HCl pH 8.0, 10 mmol/L 
imidazole, 450 mmol/L NaCl). Cells were lysed using French Press and 
rZwf was purified using 5 ml Bio- Scale Mini Nuvia IMAC Ni- Charged 
column (Bio- Rad) connected to a NGC Chromatography System (Bio- 
Rad). Bound peptides were eluted using elution buffer (20 mmol/L 
Tris- HCl pH 8.0, 250 mmol/L imidazole, 450 mmol/L NaCl). Fractions 
containing proteins were pooled, EDTA and DTT were added to final 
concentrations of 0.5 mmol/L and 1 mmol/L, respectively, and the 
His- tag was removed by overnight incubation with TEV protease (ratio 
1:100 w/w). After cleavage, the proteins were separated using Hi Load 
16/600 Superdex 75 pg column (GE Healthcare) and buffer contain-
ing 20 mmol/L Tris pH 8, 150 mmol/L NaCl connected to the NGC 
Chromatography System. Fractions containing Zwf were pooled to-
gether and concentrated using 10 kDa Vivaspin 20 concentrators (GE 
Healthcare). Glycerol was added to a final concentration of 10% and 
the protein was aliquoted and stored at −80°C.
The polyclonal rabbit anti- GmhAGC and anti- Zwf antibodies were 
generated using 6 × His- tag- free rGmhAGC and rZwf, respectively. 
Standard 13- week antibody production protocols were applied, utiliz-
ing four New Zealand White rabbits, animal handling was performed 
according to the Animal Protocol #1 approved by IACUC, in a certified 
animal facility (USDA 93- R- 283) and the NIH Animal Welfare Assurance 
Program (#A4182- 01) at the Pacific Immunology Corporation. Anti- 
GmhAGC and anti- Zwf antisera were used at 1:10,000.
2.8 | Size exclusion chromatography
The NGC Scout Chromatography system (Bio- Rad) employing a 
HiLoad 16/600 Superdex 75 pg column (GE Healthcare Life Sciences) 
was used to separate purified rGmhAGC based on the molecular 
size. Buffer for the chromatography (20 mmol/L Tris- HCl pH 8.0, 
500 mmol/L NaCl) was applied at 1 ml/min flow rate. Gel Filtration 
Standard (Bio- Rad) was used to determine the size of the separated 
proteins.
2.9 | Crystallization and structure determination of 
N. gonorrhoeae GmhAGC
The screening for initial crystallization conditions was performed 
using JCSG Core Suites I- IV (Qiagen) (Newman et al., 2005). The 
optimized crystals were grown using 0.1 mol/L Tris- HCl pH 8.5, 
0.2 mol/L magnesium chloride, 30% PEG4000. Crystals were trans-
ferred to a cryoprotectant solution supplemented with 20% glyc-
erol and flash- frozen in liquid nitrogen. The diffraction data were 
collected from a single crystal at the beamline 22- ID, Southeast 
Regional Collaborative Access Team (SER- CAT) at the Advanced 
Photon Source, Argonne National Laboratory. Data were integrated 
and scaled using XDS and XSCALE (Kabsch, 2010a). The structure was 
solved by molecular replacement using Phaser (McCoy et al., 2007) 
and structure of Pseudomonas  aeruginosa GmhA (PDB 3BJZ) as a 
search model (Taylor et al., 2008). The electron density modification 
was performed using Parrot (Cowtan, 2010) followed by automated 
model rebuilding using Buccaneer (Cowtan, 2006). The model was 
completed by manual rebuilding in Coot (Emsley, Lohkamp, Scott, & 
Cowtan, 2010) and was refined using REFMAC5 (Murshudov et al., 
2011). The structure was validated using Coot and the MolProbity 
server (Chen et al., 2010). The structural figures were generated 
using PyMol (The PyMOL Molecular Graphics System, Version 1.8 
Schrödinger, LLC.).
2.10 | SDS- PAGE and immunoblotting
Whole cell lysates of Neisseria strains indicated in the text were ei-
ther collected from solid media after 22 hr of aerobic or 48 hr of an-
aerobic growth, or harvested from liquid media following procedures 
described (Zielke et al., 2014, 2016). E. coli cells were collected from 
LB agar plates after overnight incubation. Samples were normalized 
based on OD600 values or based on total protein concentration, and 
SDS- PAGE, staining with Coomassie brilliant blue G- 250, and immu-
noblotting analyses were performed exactly as described previously 
(Zielke et al., 2014, 2016).
2.11 | Statistical analysis
GraphPad Prism’s build- in t- test was used for determination of statis-
tically significant differences between obtained experimental results. 
A confidence level of 95% was used for all analyses.
2.12 | Accession numbers
The coordinates and structure factors were deposited to the Protein 
Data Bank with accession code 5I01.
3  | RESULTS
3.1 | Chromosomal location and purification of 
GmhAGC
Genes encoding the enzymes of L,D- heptose biosynthesis pathway 
are scattered throughout the chromosome in the majority of bacteria 
including N. gonorrhoeae (Valvano et al., 2002). The GmhA homolog 
in N. gonorrhoeae strain FA1090 is encoded by ngo1986, which is lo-
cated between ngo1985, coding for an outer membrane lipoprotein 
(Zielke et al., 2014) and ngo1987 encoding a putative endonuclease 
(YraN). Comparison of the gmhA location using BioCyc Pathway/
Genome Database Collection (http://biocyc.org/) showed that this 
genetic arrangement is conserved among the various deposited 
Neisseria species and isolates (n = 70) with only a few exceptions, in-
cluding N. bacilliformis ATCC BAA- 1200, N. sp. oral taxon 020 F0370, 
N. shayeganii 871, and N. subflava NJ9703.
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GmhAGC consists of 197 amino acids with residues 37–197 com-
prising a sugar isomerase domain (SIS) (Bateman, 1999) that is shared 
between all ketose/aldose isomerases (Golinelli- Pimpaneau, Le Goffic, 
& Badet, 1989). At the amino acid level, GmhAGC shows 43–57% iden-
tity with crystallized orthologous proteins (Table 3) and contains the 
key conserved residues observed in all GmhA homologs, including 
three serine residues and a threonine that presumably interact with 
the phosphate group of sedoheptulose 7- phosphate or D- glycero- 
D- manno- heptose 7- phosphate (Harmer, 2010; Valvano et al., 2002).
To characterize GmhAGC, we first purified recombinant protein 
with an N- terminal 6 × His- tag followed by the tobacco etch virus 
(TEV) protease cleavage site and prepared untagged protein. Size ex-
clusion chromatography indicated that the native GmhAGC forms te-
trameric structures in the solution (Fig. S1A). The denatured protein 
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migrated on SDS- PAGE according to the predicted molecular mass of 
21.093 kDa (Fig. S1B). Untagged GmhAGC was subsequently used in 
crystallization and to obtain polyclonal rabbit antisera.
3.2 | N. gonorrhoeae deprived of GmhAGC displays 
defect in LOS synthesis and growth cessation
The genetic inactivation of gmhA in E. coli, Haemophilus  influenzae, 
H. ducreyi, Salmonella enterica, and Yersinia pestis resulted in altered 
outer membrane permeability and decreased virulence in animal in-
fection models, however, the mutants did not display drastic growth 
defects in vitro (Aballay et al., 2003; Bauer et al., 1998; Brooke & 
Valvano, 1996b; Darby et al., 2005). Therefore, we were surprised 
by the failure of our numerous attempts to generate a clean deletion 
of ngo1986 in N. gonorrhoeae FA1090. As an alternative strategy, an 
additional copy of gmhAGC was placed under the control of the IPTG- 
inducible Plac promoter and introduced into the chromosome of wild- 
type FA1090, followed by an allelic replacement of ngo1986 with the 
kanamycin resistance cassette. The obtained ∆gmhAGC/Plac::gmhAGC 
mutant grew scarcely after passage on solid media without IPTG, 
whereas abundant colonies were observed in the presence of the 
inducer (Figure 1a). The depletion of GmhAGC was corroborated by 
probing whole cell lysates of these gonococci with anti- GmhAGC an-
tisera (Figure 1b). Visualization of LOS species by Tricine- SDS- PAGE 
coupled with silver staining showed, as expected, that bacteria de-
prived of GmhAGC carried a truncated version of LOS that migrated 
faster in comparison with the LOS species isolated from wild- type and 
∆gmhAGC/Plac::gmhAGC grown in the presence of IPTG (Figure 1b).
Subsequently, time course experiments under standard laboratory 
growth conditions were conducted to examine the correlation between 
depletion of GmhAGC, LOS formation, and N. gonorrhoeae fitness. An 
initial suspension of nonpiliated colonies of ∆gmhAGC/Plac::gmhAGC 
collected from solid media supplemented with IPTG was divided and 
cultured in liquid media in the presence or absence of IPTG [(+) or (−), 
respectively]. After 3 hr, to ensure GmhAGC depletion, the correspond-
ing cultures were diluted to OD600 of 0.1 in media with or without 
IPTG. From this point onward (shown as 0 hr in Figure 1c–e), samples 
were withdrawn every hour to assess GmhAGC levels and LOS forma-
tion (Figure 1c), culture density (Figure 1d), and colony forming units 
(CFUs; Figure 1e). Immunoblotting with anti- GmhAGC antisera showed 
that in the absence of IPTG, GmhAGC levels were slightly decreased 
at 0 hr and complete GmhAGC depletion was achieved three hours 
later (Figure 1c). Also, it was noted that despite the presence of in-
ducer, GmhAGC had a peculiar expression pattern; decreased amounts 
of protein in comparison with these observed at 0 hr were detected 
at 1 hr and in early- log phase (corresponding to 2–3 hr data points). 
Furthermore, increased GmhAGC levels were found in late- log phase 
(4, 5 hr) followed by a decline in stationary phase (6 hr; Figure 1c–e). 
In contrast, no major differences were noticed in the overall protein 
profiles and the level of Ng- MIP (Figure 1c), which is ubiquitously ex-
pressed throughout phases of gonococci growth (Zielke et al., 2016). 
As expected based on data presented in Figure 1b, the wild- type 
LOS species diminished over time and were barely detectable upon 
GmhAGC diminution (Figure 1c). Finally, analysis of culture density and 
number of viable gonococci showed that in media lacking IPTG, bacte-
rial growth was greatly reduced concomitant to depletion of GmhAGC 
(Figure 1c–e), whereas in the presence of IPTG, the generation time of 
the ∆gmhAGC/Plac::gmhAGC mutant was 61.2 min (Figure 1d–e), a value 
similar to the parental wild- type strain (56.5 min; Figure 2b). In addi-
tion, under nonpermissive conditions, we observed that the OD600 of 
the mutant culture continued to increase (Figure 1d) while the number 
of viable bacteria remained at 107 CFUs/ml (Figure 1e). These results 
suggested that suppressors were arising in the mutant population but 
had not reached the point where they overcome the persistent popu-
lation by the end of the 6- hr growth curve. We tested this possibility 
by passaging ∆gmhAGC/Plac::gmhAGC on solid media without and with 
IPTG. After the third passage, ample bacterial colonies were obtained 
with several mutations within the Plac, allowing expression of GmhAGC 
and LOS synthesis (Fig. S2).
Together, these findings demonstrated that GmhAGC is pivotal for 
LOS synthesis and optimal growth of N. gonorrhoeae.
3.3 | GmhAGC subcellular localization and 
expression patterns
Preliminary results and absence of signal peptide suggested that 
GmhA of E. coli is a cytoplasmic enzyme (Brooke & Valvano, 1996a). 
However, subcellular localization of GmhA and expression patterns 
F IGURE  1 GmhAGC is pivotal for N. gonorrhoeae growth and lipooligosaccharide (LOS) synthesis. (a) The N. gonorrhoeae FA1090 gmhAGC 
conditional knockout strain, ∆gmhAGC/Plac::gmhAGC, was streaked out from frozen glycerol stock on solid media supplemented with 20 μmol/L 
isopropyl β- D- 1- thiogalactopyranoside (IPTG). After 18 hr incubation at 37°C in the presence of 5% atmospheric CO2, the colonies were 
passaged onto plates either with (+) or without IPTG (−). (b) Whole cell lysates of FA1090 wild- type and isogenic ∆gmhAGC/Plac::gmhAGC 
harvested from plates with (+) or without 20 μmol/L IPTG (−) were either probed with polyclonal rabbit antisera or subjected to LOS extraction 
using proteinase K followed by silver staining. (c–e) The FA1090 ∆gmhAGC/Plac::gmhAGC cells were collected from solid media supplemented with 
20 μmol/L IPTG, suspended to OD600 of 0.1, washed twice, divided, and cultured either in the presence or absence of IPTG for 3 hr. At time 
point designated as 0 hr, corresponding cultures were back- diluted to the same density (OD600 of 0.1) into fresh media with or without IPTG 
and incubated for additional 6 hr. Samples of bacterial cultures were collected every hour for GmhAGC and Ng- MIP immunoblotting analysis, 
LOS, and whole cell protein profiles (c), monitoring of bacterial proliferation by measurement of density of the cultures at OD600, (d) and spotting 
serially diluted bacteria on solid media with IPTG for CFU scoring (e). Whole cell lysates were matched by the same OD600 units. As loading 
control, samples separated by SDS- PAGE were either probed with anti- Ng- MIP antibodies or stained with Coomassie brilliant blue  
G- 250. The migration of molecular mass marker (kDa) is indicated on the left. All experiments were performed in three biological replicates. 
Means and SEM are presented on graphs; *p < .05
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were never assessed. To examine the localization of GmhAGC, 
N. gonorrhoeae FA1090 was harvested at mid- logarithmic phase 
of growth and subjected to subfractionation procedures. Equal 
amounts of extracted proteome fractions including cytoplasm, cell 
envelopes, naturally released membrane vesicles, and soluble pro-
teins in culture supernatants were separated by SDS- PAGE and 
probed with polyclonal antibodies (Figure 2a). GmhAGC was found 
solely in the cytoplasmic protein fraction, similarly to the cytoplasmic 
F IGURE  3 GmhAGC expression in a 
panel of N. gonorrhoeae isolates. Whole 
cell lysates of E. coli, wild- type FA1090, 
∆gmhAGC/Plac::gmhAGC grown either 
with (+) or without (−) isopropyl β- D- 1- 
thiogalactopyranoside (IPTG), and 36 
additional strains of N. gonorrhoeae were 
resolved on a 10–20% Tris- Glycine gel 
and probed with anti- GmhAGC antibodies. 
Immunoblotting with anti- Zwf antisera was 
used as a loading control. Migration of a 
molecular mass marker (kDa) is indicated 
on the left
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F IGURE  2 Assessment of GmhAGC subcellular localization and expression patterns. (a) N. gonorrhoeae wild- type FA1090 cells were harvested 
during mid- exponential phase and subjected to proteome extraction to separate cytoplasmic/periplasmic proteins (C), cell envelopes (CE), 
naturally released membrane vesicles (MVs), and soluble proteins in culture supernatants (SS). Individual fractions were loaded based on the 
total amount of protein (μg) and probed with antisera as indicated on the left. (b–c) Wild- type N. gonorrhoeae FA1090 was cultured in liquid 
media and at indicated time points, OD600 measurements were taken (b) and samples were withdrawn and processed for immunoblotting 
analysis of GmhAGC and Ng- MIP (c). (d) Quantities of GmhAGC and lipooligosaccharide (LOS) in wild- type FA1090 during in vitro conditions 
relevant to different infection sites [standard growth under aerobic conditions (SGC), iron deprivation (- Iron), presence of normal human serum 
(+NHS), and anaerobiosis (- O2)], were assessed by probing the whole cell lysates with anti- GmhAGC antibodies and silver staining of proteinase 
K- extracted LOS, respectively. Immunoblotting experiments with antisera against Ng- MIP, TbpB, and AniA were used as markers for ubiquitous 
expression, iron- limiting, and anaerobic conditions, respectively. (e) Effect of overexpression of GmhAGC on LOS amounts was examined by 
harvesting wild- type FA1090 and isogenic ∆gmhAGC/Plac::gmhAGC grown on solid media with different isopropyl β- D- 1- thiogalactopyranoside 
(IPTG) concentrations (0, 20, or 1,000 μmol/L). Whole cell lysates were either probed with anti- GmhAGC antisera or treated with proteinase 
K and LOS was visualized by silver staining. Experiments were performed in biological triplicates and representative immunoblots and silver- 
stained gels are shown. Mean values and corresponding SEM are presented on the graph. Migration of a molecular mass marker (kDa) is 
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enzyme glucose- 6- phosphate 1- dehydrogenase, Zwf. As expected, 
the GTPase Obg (ObgGC), which primarily associates with 50S ribo-
somal subunits and partly with the peripheral inner membrane pro-
teome (Papanastasiou et al., 2013; Zielke et al., 2015), was detected 
mainly in the cytoplasm and minute amounts were also found in the 
cell envelope fraction; whereas, antisera against the outer membrane 
protein marker BamA (Zielke et al., 2016) cross- reacted with fractions 
containing cell envelopes and membrane vesicles.
The expression of GmhAGC was subsequently examined in 
wild- type FA1090 during routine aerobic growth in liquid media 
(Figure 2b–c) and on solid media under conditions that more closely 
mimic clinical infection, such as iron deprivation, exposure to human 
serum, and anoxia (Figure 2d). Antibodies against Ng- MIP, TbpB, and 
AniA were used as markers for ubiquitous expression, iron- limiting 
conditions, and anaerobiosis, respectively (Cornelissen, 2008; Zielke 
et al., 2014, 2016). Immunoblotting analyses of whole cell lysates 
showed that expression of GmhAGC peaked during mid- exponential 
phase (3 and 4 hr, Figure 2b–c). Increased GmhAGC levels were also 
detected during iron deprivation and anaerobic growth in compari-
son with standard laboratory conditions (Figure 2d). As expected, ex-
pression of Ng- MIP remained constant throughout different phases 
of gonococcal growth and was unchanged under all tested conditions 
(Zielke et al., 2015, 2016), while TbpB and AniA were the most highly 
upregulated during iron deprivation and anaerobic growth, respec-
tively (Figure 2d).
The increase in GmhAGC expression did not influence LOS migra-
tion patterns in wild- type gonococci, albeit increased amounts of total 
LOS were observed in bacteria cultured in the presence of normal 
human serum and anaerobically (Figure 2d). To further assess the pos-
sible correlation between expression of GmhAGC and LOS levels, ∆gm-
hAGC/Plac::gmhAGC was cultured in increasing concentrations of IPTG. 
The vast overexpression of GmhAGC achieved with 1,000 μmol/L IPTG 
did not have adverse effect on bacterial growth (data not shown) and 
had no effect on the LOS quantities (Figure 2e).
Cumulatively, these experiments demonstrated that GmhAGC 
is a cytoplasmic enzyme with augmented expression during mid- 
logarithmic phase, iron depletion and anaerobiosis, and that overpro-
duction of GmhAGC alone does not alter gonococcal LOS abundance.
3.4 | Conservation of gmhA among Neisseria
Analysis of gmhA conservation showed that the gene (locus NGO1986, 
NMB2090, NMC2070) is present in all of the 39,182 Neisseria spp. 
genomes deposited into the PubMLST database (http://pubmlst.org/
neisseria/ as of July, 20, 2016) and that there are 340 alleles and 323 
single nucleotide polymorphic sites (Fig. S4).
Expression of GmhAGC among 36 different N. gonorrhoeae strains 
isolated from patients at different times and geographic locations, 
 including the 2016 WHO reference strains (Unemo et al., 2016), 
was also assessed by immunoblotting. Whole cell lysates were re-
solved by SDS- PAGE and probed with either polyclonal anti- GmhAGC 
 antisera or Zwf antibodies, or stained with Coomassie brilliant blue 
G- 250 as a loading control. Antisera against GmhAGC cross- reacted 
with all clinical isolates of N. gonorrhoeae, but no cross- reactivity was 
detected for the E. coli GmhA homolog (Figure 3). In addition, there 
were noticeable differences in GmhAGC protein abundance between 
the strains, while Zwf was uniformly expressed and there were no dis-
crepancies in regard to samples normalization and loading (Figure 3 
and Fig. S3).
F IGURE  4 Hindering GmhAGC isomerase activity does not 
influence N. gonorrhoeae growth. (a) Wild- type FA1090 and 
isogenic conditional mutants carrying either native gmhAGC 
(∆gmhAGC/Plac::gmhAGC) or mutated variants of GmhAGC 
(∆gmhAGC/Plac::gmhAGCE65A or ∆gmhAGC/Plac::gmhAGCH183A) were 
collected from solid media with (+) and without (−) isopropyl β- D- 
1- thiogalactopyranoside (IPTG). Expression of individual GmhAGC 
variants and lipooligosaccharide (LOS) patterns were examined 
in whole cell extracts by immunoblotting and silver staining, 
respectively. Samples were matched by equivalent OD600 units. 
Migration of a molecular mass marker (kDa) is indicated on the left. 
(b) Wild- type FA1090 and conditional mutants ∆gmhAGC/Plac::gmhAGC, 
∆gmhAGC/Plac::gmhAGCE65A, and ∆gmhAGC/Plac::gmhAGCH183A were 
collected from solid media supplemented with 20 μmol/L IPTG, 
suspended in liquid media to OD600 of 0.1, cultured for 3 hr, back- 
diluted to equal OD600 of 0.2, serially diluted, and spotted on solid 
media in the presence (+) and absence (−) of IPTG. CFUs were scored. 
The data show averages of CFUs with corresponding SEM of at least 
three separate experiments; *p < .05
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3.5 | Hindering GmhAGC isomerase activity does not 
influence N. gonorrhoeae growth
The crucial side chains for GmhA enzymatic activity appeared to be 
E65 and H180 in the E. coli ortholog as analyzed by in vitro kinetic 
assays, LOS synthesis, and novobiocin sensitivity studies. It has been 
proposed that these two residues act as the base and the acid, re-
spectively, to promote the isomerization reaction of D- sedoheptulose 
7- phosphate into D- glycero- α,β- D- manno- heptose- 7- phosphate 
(Taylor et al., 2008). Therefore, to determine whether the observed 
decrease in N. gonorrhoeae survival upon GmhAGC depletion is a con-
sequence of abolished LOS synthesis, site- directed mutagenesis of 
corresponding residues (E65 and H183 in GmhAGC) was employed. 
The obtained GmhAGC E65A and H183A variants were placed under 
the IPTG- inducible promoter and introduced into the chromosome of 
wild- type FA1090, followed by allelic exchange of ngo1986 with the 
kanamycin resistance cassette. Both mutated proteins were stably 
produced in N. gonorrhoeae; however, the H183A variant was pre-
sent at higher levels than the wild- type GmhAGC (Figure 4a). Silver 
staining analysis of LOS revealed that bacteria expressing either 
E65A or H183A constructs produced truncated LOS, regardless of 
the presence of IPTG (Figure 4a). Furthermore, under nonpermis-
sive conditions (without IPTG), the ∆gmhAGC/Plac::gmhAGCE65A and 
∆gmhAGC/Plac::gmAGCH183A, similar to the ∆gmhAGC/Plac::gmhAGC, 
had decreased viability, which was demonstrated by a 3214- , and 
8653- fold decline, respectively, in CFUs in comparison with wild- 
type gonococci (Figure 4b). In contrast, the expression of either mu-
tated version of GmhAGC rescued bacterial viability to the wild- type 
level.
These in vivo studies demonstrated the importance of residues 
E65 and H183 in GmhAGC activity in the production of full- length LOS 
and suggested that abolition of LOS synthesis is disconnected from 
the GmhAGC- dependent effect on N. gonorrhoeae viability.
3.6 | Transcomplementation studies of GmhA
GmhA homologs of H. influenzae and H. ducreyi restored the syn-
thesis of full- length LPS in the E. coli ∆gmhA mutant (Bauer et al., 
1998; Brooke & Valvano, 1996a). This suggested that GmhA pro-
teins can function interchangeably. However, failure of multiple 
attempts to remove ngo1986 in FA1090 carrying the E. coli gmhA 
gene cloned under the Plac promoter and integrated into the chro-
mosome ruled out the possibility of a functional interspecies com-
plementation. The E. coli GmhA (GmhAEC) shares 74% and 75% 
amino acid identity with H. influenzae and H. ducreyi proteins, re-
spectively, while only 50% identity exists between GmhAEC and 
GmhAGC (Table 3). In contrast, N. meningitidis GmhA (GmhANM) 
shows 98% identity to GmhAGC, and anti- GmhAGC antisera read-
ily recognized GmhANM (Figure 5a). Therefore, we decided to use 
an analogous strategy to create N. gonorrhoeae and N. meningitidis 
∆gmhA strains expressing either endogenous or nonendogenous 
GmhA. Immunoblotting experiments demonstrated that under per-
missive conditions, both proteins were stably expressed in each 
host, while without IPTG, neither GmhAGC nor GmhANM were de-
tected (Figure 5a). Functional interchangeability of GmhA between 
N. gonorrhoeae and N. meningitidis was then evaluated by analysis 
of LOS patterns. In FA1090, ∆gmhAGC/Plac::gmhANM expression 
of GmhANM resulted in LOS migrating exactly as LOS species ex-
tracted from the wild- type gonococci (Figure 5a). Likewise, expres-
sion of GmhAGC restored LOS synthesis in the N. meningitidis MC58 
∆gmhANM/Plac::gmhAGC. Furthermore, as expected from our studies 
in N. gonorrhoeae (Figure 1), depletion of GmhANM in N. meningitidis 
F IGURE  5 Homologs of GmhA from N. gonorrhoeae and 
N. meningitidis function interchangeably. (a) N. gonorrhoeae FA1090 
wild- type and isogenic conditional gmhA mutants bearing either 
endogenous (∆gmhAGC/Plac::gmhAGC) or N. meningitidis- derived 
gmhANM (∆gmhAGC/Plac::gmhANM), as well as N. meningitidis MC58 
wild- type and conditional gmhA mutants carrying gmhA alleles 
(∆gmhANM/Plac::gmhANM or ∆gmhANM/Plac::gmhAGC) were harvested 
from GCB after 22 hr of incubation either with (+) or without 
(−) isopropyl β- D- 1- thiogalactopyranoside (IPTG). Whole cell 
lysates were probed with anti- GmhAGC antibodies or treated with 
proteinase K and lipooligosaccharide (LOS) was visualized by silver 
staining. Migration of a molecular mass marker (kDa) is indicated 
on the left. (b) Wild- type and mutant strains of N. gonorrhoeae 
and N. meningitidis, as described above, were collected from 
GCB supplemented with 20 μmol/L IPTG and 15 μmol/L IPTG, 
respectively. Bacteria were suspended in gonococcal base liquid 
(GCBL) to OD600 of 0.1, cultured for 3 hr, back- diluted to equal OD600 
of 0.2, serially diluted, and plated on GCB with (+) and without (−) 
IPTG. CFUs were counted following 22 hr of incubation. Experiments 
were performed in three independent replicates. Mean values and 
SEM are presented; *p < .05
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MC58 ∆gmhANM/Plac::gmhANM had adverse effects on bacterial vi-
ability and resulted in a 300- and 235.7- fold decrease in CFUs in 
comparison with wild- type and ∆gmhANM/Plac::gmhANM cultured in 
the presence of IPTG, respectively (Figure 5b). There was no sta-
tistically significant difference in the number of CFUs between 
the wild- type N. gonorrhoeae and its isogenic ∆gmhAGC mutant 
expressing either GmhAGC or GmhANM (Figure 5b). Similarly, both 
GmhANM and GmhAGC fully complemented the lack of GmhANM in 
N. meningitidis.
Together, the transcomplementation studies showed that the 
N. gonorrhoeae and N. meningitidis GmhA can function interchange-
ably. Expression of either of the homologs restored both viability and 
LOS synthesis. Additionally, we concluded that E. coli GmhAEC is not 
able to complement GmhAGC functions, as we were not able to gener-
ate a viable N. gonorrhoeae ∆gmhAGC/Plac::gmhAEC mutant.
3.7 | The structure of N. gonorrhoeae GmhA
To gain insights into the function of GmhAGC and to facilitate the 
future targeting of this enzyme with small molecule inhibitors, we 
obtained recombinant protein for structural studies (Fig. S1). The 
structure of N. gonorrhoeae GmhA was determined by molecular re-
placement and was refined to 2.37 Å resolution with Rwork 0.207, Rfree 
0.267, and excellent stereochemical parameters (Table 2). Four mono-
mers of GmhAGC were present in the asymmetric unit (Figure 6a). The 
tetrameric architecture is consistent with the results of size exclusion 
chromatography (Fig. S1A), and with the previously determined struc-
tures of GmhA homologs from other bacteria (Table 3). The interface 
area of the GmhAGC tetramer is extensive and buries 14,160 Å
2 of sur-
face area as calculated by the PISA server (Krissinel & Henrick, 2007). 
Four subunits of GmhAGC adopt highly similar structures with root 
mean square deviation (r.m.s.d.) 0.1–0.2 Å between subunits. Residues 
69–74 (chains A and B) and 69–75 (chains C and D) are disordered in 
the structure. These residues form a loop in the vicinity of the active 
site and could become ordered upon substrate binding. A similar dis-
order was observed in the homologous region of E. coli GmhA (Taylor 
et al., 2008).
Each monomer of GmhAGC is composed of a central five- stranded 
parallel β- sheet flanked by four α- helices from each side (Figure 6b). 
Four zinc ions are present in the GmhAGC tetramer. The zinc ions are 
coordinated by the side chains of residues H61, E65, and H183 of 
one monomer, and the side chain of Q175 of the neighboring mono-
mer (Figure 6c). Therefore, the zinc- binding sites of GmhAGC are 
identical to the zinc- binding sites of B. pseudomallei GmhA (Harmer, 
2010).
Overall, the structure of GmhAGC is similar to the previously de-
termined structures of GmhA from other bacteria, as well as E. coli 
DiaA (Table 3). The monomer structure of GmhAGC could be super-
imposed to the homologous structures with r.m.s.d. of 0.5–1.4 Å. The 
tetramer structure of GmhAGC forms a “closed” conformation, similar 
to the GmhA structures of P. aeruginosa, V. cholerae, B. pseudomallei, 
and C. psychrerythraea (Do et al., 2015; Harmer, 2010; Seetharaman 
et al., 2006; Taylor et al., 2008).
4  | DISCUSSION
GmhA is a conserved sedoheptulose- 7- phosphate isomerase involved 
in the first biosynthesis step of the L,D- heptose component of the 
LPS/LOS. Deprivation of heptoses results in pleiotropic phenotypes 
including synthesis of LPS/LOS molecules composed only of lipid A 
and KDO residues, increased susceptibility to antimicrobial agents, 
defects in plasmid F conjugations and P1 bacteriophage transduction, 
and decreased virulence and biofilm formation (Bauer et al., 1998; 
TABLE  2 Data collection and refinement statistics
N. gonorrhoeae GmhAGC 
(PDB 5I01)
Data collection
Wavelength (Å) 1.0000
Space group P21212
Cell dimensions: 
a, b, c (Å) 114.36, 130.15, 47.15
α, β, γ (°) 90, 90, 90
Resolution (Å) 85.91–2.37 (2.43–2.37)a
Rsym 0.134 (1.032)
CC1/2
b 99.6 (62.4)
I/σI 9.3 (1.7)
Completeness (%) 95.8 (97.8)
Multiplicity 3.7 (3.6)
Refinement
Resolution (Å) 85.91–2.37
No. reflections (total/free) 28191/1405
Rwork/Rfree 0.207/0.267
Number of atoms:
Protein 5411
Ligand/ion 4
Water 101
B- factors:
Protein 37.6
Ligand/ion 54.9
Water 32.7
All atoms 37.2
Wilson B 41.2
R.m.s. deviations:
Bond lengths (Å) 0.009
Bond angles (°) 1.224
Ramachandran distributionc (%):
Favored 97.8
Outliers 0
aValues in parentheses are for the highest resolution shell.
bCC1/2 correlation coefficient as defined in (Karplus & Diederichs, 2012) 
and calculated by XSCALE (Kabsch, 2010b).
cCalculated using the MolProbity server (http://molprobity.biochem.duke.
edu) (Chen et al., 2010).
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Brooke & Valvano, 1996a; Earl et al., 2015; Havekes et al., 1976; 
Malott et al., 2013; Tamaki et al., 1971). In N. gonorrhoeae, heptoses 
are also crucial for LOS function in the evasion of the host immune 
system and induction of HIV expression (Malott et al., 2013; Preston 
et al., 1996). Variability in LOS molecules on the gonococcal surface 
is driven by phase variable enzymes responsible for decorating the 
sugar moiety of the outer core oligosaccharide (Apicella et al., 1987; 
Danaher et al., 1995). N. gonorrhoeae scavenges sialic acid from the 
human body and modifies the lacto- N- neotetraose attached to the 
HepI of the LOS core oligosaccharide, which provides protection from 
killing by classical and alternative complement pathways (Elkins et al., 
1992; Ram et al., 1998). Thus, inhibition of GmhA could aid in treat-
ment of infections caused by different pathogenic bacteria including 
N. gonorrhoeae.
Accordingly, in this work, we presented initial characterization 
of GmhAGC at the functional and structural levels. Our experiments 
demonstrated that gonococci and meningococci depleted in GmhA 
produced overall significantly less LOS molecules that migrated 
faster in comparison with the LOS- derived from wild- type bacteria 
(Figures 1b and 5a). In contrast to other orthologs, however, diminu-
tion of the GmhA cellular pool had severe consequences on neisserial 
growth (Figures 1a, d–e and 5b). This protein is likely not essential for 
bacterial viability, as GmhA-depleted neisserial cells still arose on solid 
media under nonpermissive conditions (Figure 1a, d–e). Corroborating 
this observation, gmhAGC was not found among 827 gonococcal core 
essential genes identified using a high- density Tn5 transposon library 
(Remmele et al., 2014). In addition, expression of GmhAGC variants 
carrying substitutions in the catalytic residues coordinating zinc ions, 
E65, and H183 (Figure 6c), led to synthesis of truncated LOS while 
retaining ample N. gonorrhoeae viability (Figure 4). These findings 
suggested that GmhAGC may be involved in additional physiological 
function(s) in Neisseria. Not surprisingly, a complete functional trans-
complementation was achieved between GhmAGC and GmhANM 
(Figure 5a–b), whereas multiple attempts to generate a viable strain of 
N. gonorrhoeae expressing only GmhAEC were unsuccessful (data not 
shown). Based on these findings, we concluded that GmhA plays a crit-
ical role in LOS synthesis and is a fundamental growth factor for both 
N. gonorrhoeae and N. meningitidis.
Profiling of GmhAGC expression showed that amounts of GmhAGC 
increased during exponential growth of wild- type N. gonorrhoeae 
(Figure 2c). Surprisingly, the isogenic conditional ∆gmhAGC/Plac::gm-
hAGC mutant cultured in the presence of IPTG had elevated levels of 
GmhAGC during the late logarithmic phase (Figure 1c–e), suggesting 
that expression of GmhAGC is regulated at the posttranscriptional (e.g., 
small noncoding RNAs, RNA- binding proteins, RNases, and thermos- 
switches) or posttranslational levels. Higher amounts of GmhAGC were 
also noted upon exposure of N. gonorrhoeae to environmental cues 
relevant to infection; iron deprivation and anaerobiosis (Figure 2d). 
Transcriptomic studies, however, did not identify GmhAGC as an iron- 
regulated gene (Ducey, Carson, Orvis, Stintzi, & Dyer, 2005; Jackson 
F IGURE  6 The structure of 
N. gonorrhoeae GmhAGC. (a) The ribbon 
representation of GmhAGC tetramer with 
monomers colored in green, yellow, cyan, 
and magenta. Zn2+ ions are shown as gray 
spheres. (b) The structure of GmhAGC 
monomer is colored in rainbow colors 
from blue (N- terminus) to red (C- terminus). 
The α- helices are labeled according to 
Seetharaman et al., 2006. (c) A close- up 
view of the Zn2+- binding site of GmhAGC. 
The coordinating side chains are shown 
in stick representation. The σA- weighted 
2FO–FC electron density map countered at 
1.0 σ is displayed as blue mesh
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et al., 2010). The observed upregulation of GhmAGC under anaerobic 
conditions was in agreement with deep sequencing analysis of the 
N. gonorrhoeae anaerobic stimulon, where gmhAGC was found to be 
4.2- and 6.1- fold upregulated in two biological experiments (Isabella & 
Clark, 2011). Higher levels of enzymes acting downstream from GmhA 
including HldA (NGO0402) and GmhB (NGO2070) were identified in 
anaerobically versus aerobically cultured gonococci in our recent high- 
throughput proteomic studies (Zielke et al., 2016), suggesting that 
the L,D- heptose biosynthesis pathway is upregulated during anoxia. 
Accordingly, increased amounts of LOS were detected in anaerobically 
grown gonococci (Figure 2d), while vast overexpression of GhmAGC 
alone had no effect on LOS levels (Figure 2e). GmhAGC expression 
was also studied in a diverse collection of gonococcal isolates, includ-
ing the 2016 WHO reference strains (Unemo et al., 2016) containing 
multidrug- resistant N. gonorrhoeae (Figure 3). Potential involvement 
of GmhA in antibiotic resistance via increased synthesis of LPS was 
suggested recently in Salmonella typhimurium DT104B multiresis-
tant strain with additional fluoroquinolone resistance (Correia et al., 
2016). Notwithstanding this suggestion, the amounts of GmhAGC var-
ied widely between the WHO strains K, L, V, W, X, Y, and Z, which 
display overall high levels of ciprofloxacin resistance (MIC>32 mg/L) 
and decreased susceptibility to gemifloxacin and moxifloxacin (Unemo 
et al., 2016). Additionally, strain L, which has high MICs for all quino-
lones (MICs in mg/L for ciprofloxacin, gemifloxacin, and moxifloxacin 
of >32, 8, and 16, respectively), showed significantly lower GmhAGC 
levels in comparison with WHO isolates F, O, P, and U, which are all 
ciprofloxacin sensitive (MIC of 0.004 mg/L) and are significantly more 
sensitive to gemifloxacin and moxifloxacin (MICs ranging from 0.004 
to 0.016 mg/L).
Finally, to better understand the pivotal function of GmhAGC, we 
have determined the three- dimensional structure of the untagged 
enzyme (Figure 6). Comparison of our GmhAGC crystal structure with 
the structures of homologs from other bacteria did not reveal signifi-
cant differences in the general organization of the structure or within 
the catalytic site of the enzyme. Zinc ions were not added to any of 
the protein purification steps or crystallization buffers, yet similar to 
Burkholderia  pseudomallei GmhA (Harmer, 2010), GmhAGC held zinc 
ions in the active site (Figure 6c), providing further support that GmhA 
is a metalloenzyme. Zinc is likely retained from the cell of the heter-
ologous host during protein overproduction and natively bound to 
the active site of the enzyme. Zinc binding likely drives the “closed” 
conformation of GmhAGC, which was also observed in structures of 
B. pseudomallei, P. aeruginosa, and V. cholerae GmhA (Table 3), thus pro-
viding further support that the “closed” conformation is catalytically 
relevant. In addition, site- directed mutagenesis coupled with in vivo 
studies confirmed the pivotal function of GmhAGC E65 and H183 in 
the isomerization of the sedoheptulose- 7- phosphate (Figures 4 and 6).
In conclusion, understanding the function and structure of individ-
ual GmhA proteins will facilitate drug discovery approaches focused 
on targeting this protein with small molecule inhibitors. In particular, 
our work demonstrated the crucial function of GmhA in neisserial 
growth and LOS synthesis, positive regulation of expression by host- 
relevant environmental stimuli, and conservation among different iso-
lates, as well as provided further support for the mode of action of 
GmhA. These findings underscore the significance of GmhAGC as a tar-
get for antigonorrhea therapeutics. Future work involving determining 
the interacting partner(s) of GmhAGC and analysis of global changes 
at the proteome and metabolome levels are required to elucidate the 
whole scope of physiological function(s) of GmhAGC in N. gonorrhoeae.
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